LONDON, July 24 (Reuters) - AstraZeneca's (AZN.L), opens new tab long-time CEO Pascal Soriot has rarely put a foot wrong. The company's shares have more that quadrupled in price during his ‌14-year ...

AstraZeneca announced forecast-beating revenue on Tuesday. AstraZeneca's chief executive on Tuesday teased the prospect of a weight-loss drug in development that the company moved into late-stage ...

AstraZeneca CEO Pascal Soriot joins CNBC’s Angelica Peebles to discuss the most promising drugs in AstraZeneca’s pipeline. He says the future is about innovating into new indications with the drugs ...

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic. "This country [the U.S.] ...

AstraZeneca CEO Pascal Soriot said it’s time for the U.S. to start paying more reasonable prices for new drugs, which are closer to what other wealthy countries pay, in a rare stance in an industry ...

Pharmaceutical giant AstraZeneca (AZN) topped first quarter earnings and revenue estimates, while the drugmaker's stock dips slightly in Wednesday's trading session. AstraZeneca CEO Pascal Soriot ...

Add Yahoo as a preferred source to see more of our stories on Google. U.S. President Donald Trump speaks during an announcement about lowering U.S. drug prices next to Secretary of Commerce Howard ...